menu toggle

October 27, 2024

Now available PAVBLU™

PAVBLU™ (aflibercept-ayyh) injection, for intravitreal use, is a vascular endothelial growth factor (VEGF) inhibitor
indicated for the treatment of patients with:

  • Neovascular (Wet) Age-Related Macular Degeneration (AMD)
  • Macular Edema Following Retinal Vein Occlusion (RVO)
  • Diabetic Macular Edema (DME)
  • Diabetic Retinopathy (DR)

View full prescribing information.